Business
CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17
REHOVOT, Israel, Nov. 3, 2022 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative
About this update from Collplant Biotechnologies Ltd.
[{"type":"text","content":"REHOVOT, Israel, Nov. 3, 2022 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative human-collagen based technologies and products for tissue regeneration and organ manufacturing, today announced that Eran Rotem, Collplant's Deputy CEO and Chief Financial Officer, will present a company overview at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum at the Westin NY Grand Central Hotel. \n\n \n \n \n \n \n \n\n \nMr. Rotem's presentation will take place on Thursday, November 17 at 2:00 p.m. ET.\nInvestors attending the event may request a one-on-one meeting with CollPlant through the conference coordinators.\nAbout CollPlantCollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The Company's products are based on its recombinant human collagen product with CollPlant's proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing, ushering in a new era in regenerative and aesthetic medicine. \nAt the beginning of 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market. Later in 2021, CollPlant entered into a strategic co-development agreement with 3D Systems for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant. \nFor more information, visit http://www.collplant.com.\nSafe Harbor StatementsThis press release may include forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to CollPlant's objectives plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that CollPlant intends, expects, projects, believes or anticipates will or may occur in the future. These statements are often characterized by terminology such as \"believes,\" \"hopes,\" \"may,\" \"anticipates,\" \"should,\" \"intends,\" \"plans,\" \"will,\" \"expects,\" \"estimates,\" \"projects,\" \"positioned,\" \"strategy\" and similar expressions and are based on a...